MCL-1 is a protein found in our bodies that some of our cells use to maintain normal function and protect themselves. Researchers have found that certain kinds of cancer cells have a large amount of this protein. This may contribute to the cancer cells ability to rapidly grow, and help it protect itself from anticancer therapy.
A new type of drug, an MCL-1 inhibitor, is being tested for use in multiple myeloma. Researchers think they could work by preventing cancer cells from using the MCL-1 protein, which may cause cell death.
The following is a listing of myeloma treatments associated with this tag.
View all treatments in development for myeloma patients around the US.
The following is a listing of treatments in development for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of treatments in development for patients with multiple myeloma who have received three or more prior lines of therapy.
The following is a listing of myeloma clinical trials associated with this tag.
View all active clinical trials around the US.
The following is a listing of clinical trials for patients with multiple myeloma who have received one to two prior lines of therapy.
The following is a listing of clinical trials for patients with multiple myeloma who have received three or more prior lines of therapy.
There are no resources, links or videos to display for this tag.